Derivation of age-adjusted LACE index thresholds in the prediction of mortality and frequent hospital readmissions in adults.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 04 2020
accepted: 10 07 2020
pubmed: 30 7 2020
medline: 3 7 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

The LACE index has been shown to predict hospital readmissions and death with variable accuracy. A LACE index ≥ 10 is considered as high risk in the existing literature. We aimed to derive age-specific LACE index thresholds in the prediction of mortality and frequent readmissions. Analysis of prospectively collected data of consecutive alive-discharge episodes between 01/04/2017 and 31/03/2019 to a single hospital was conducted. The derivation of LACE index thresholds for predicting all-cause mortality within 6 months of hospital discharge or frequent readmissions (≥ 2 times within 28 days) was examined by receiver operating characteristics (ROC) in 32270 patients (14878 men, 17392 women) aged 18-107 year (mean = 64.0 years, SD = 20.5). For all patients with a LACE index ≥ 10, the area under the curve (AUC) for predicting mortality was 80.5% (95% CI 79.7-81.3) and for frequent readmissions was 84.0% (83.0-85.1). Two-graph ROC plots showed that the LACE index threshold where sensitivity equates specificity was 9.5 (95% intermediate range = 5.6-13.5) for predicting mortality and 10.3 (95% intermediate range = 6.6-13.6) for frequent readmissions. These thresholds were lowest among youngest individuals and rose progressively with age for mortality prediction: 18-49 years = 5.0, 50-59 years = 6.5, 60-69 years = 8.0, 70-79 years = 9.8 and ≥ 80 years = 11.6, and similarly for frequent readmissions: 18-49 years = 5.1, 50-59 years = 7.5, 60-69 years = 9.1, 70-79 years = 10.6 and ≥ 80 years = 12.0. Positive and negative likelihood ratios (LRs) ranged 1.5-3.3 and 0.4-0.6 for predicting mortality, and 2.5-4.4 and 0.3-0.6 for frequent readmissions, respectively, with stronger evidence in younger than in older individuals (LRs further from unity). In conclusion, the LACE index predicts mortality and frequent readmissions at lower thresholds and stronger in younger than in older individuals. Age should be taken into account when using the LACE index for identifying patients at high risk.

Identifiants

pubmed: 32725518
doi: 10.1007/s11739-020-02448-3
pii: 10.1007/s11739-020-02448-3
pmc: PMC7511461
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1319-1325

Références

Circulation. 2015 May 19;131(20):1796-803
pubmed: 25986448
J Clin Anesth. 2019 Dec;58:22-26
pubmed: 31055196
Obes Res. 1996 Nov;4(6):533-47
pubmed: 8946438
Health Serv Res. 2003 Aug;38(4):1103-20
pubmed: 12968819
J Clin Epidemiol. 1993 Oct;46(10):1075-9; discussion 1081-90
pubmed: 8410092
BMC Med Inform Decis Mak. 2015 May 20;15:39
pubmed: 25991003
Aging Clin Exp Res. 2020 Jun 5;:
pubmed: 32504318
Int J Epidemiol. 1985 Mar;14(1):32-8
pubmed: 3872850
BMJ Qual Saf. 2017 Oct;26(10):782-785
pubmed: 28615343
Lancet. 2005 Apr 23-29;365(9469):1500-5
pubmed: 15850636
BMJ. 2004 Jul 17;329(7458):168-9
pubmed: 15258077
BMC Cardiovasc Disord. 2014 Aug 07;14:97
pubmed: 25099997
BMJ. 2005 Feb 5;330(7486):289-92
pubmed: 15695276
BMJ. 2012 Sep 18;345:e6017
pubmed: 22990102
CMAJ. 2010 Apr 6;182(6):551-7
pubmed: 20194559
Neurol Sci. 2019 Aug;40(8):1659-1665
pubmed: 31030369
Open Med. 2011;5(2):e104-11
pubmed: 21915234
BMC Health Serv Res. 2013 Sep 29;13:366
pubmed: 24074454
Rand Health Q. 2012 Mar 1;2(1):10
pubmed: 28083232
Am J Med. 2017 May;130(5):601.e17-601.e22
pubmed: 28065773
J Immunol Methods. 1995 Sep 11;185(1):123-32
pubmed: 7665894
Am J Med. 1998 Dec;105(6):506-12
pubmed: 9870837
Lancet. 1998 Dec 5;352(9143):1808-12
pubmed: 9851380
Calcif Tissue Int. 2020 Oct;107(4):319-326
pubmed: 32653943
BMJ. 2016 Jan 28;352:h6817
pubmed: 26822070
JAMA. 2017 Feb 7;317(5):530-531
pubmed: 28114505
Circulation. 2007 Feb 6;115(5):654-7
pubmed: 17283280
Age Ageing. 2012 Nov;41(6):784-9
pubmed: 22644078

Auteurs

Christopher Henry Fry (CH)

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK.

Erica Heppleston (E)

Quality Department, Ashford and St Peter's NHS Foundation Trust, Guildford Road, Chertsey, Surrey, KT16 0PZ, UK.

David Fluck (D)

Department of Cardiology, Ashford and St Peter's NHS Foundation Trust, Guildford Road, Chertsey, Surrey, KT16 0PZ, UK.

Thang Sieu Han (TS)

Department of Endocrinology, Ashford and St Peter's NHS Foundation Trust, Guildford Road, Chertsey, Surrey, KT16 0PZ, UK. thang.han@rhul.ac.uk.
Institute of Cardiovascular Research, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK. thang.han@rhul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH